Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Network Type I Analysis

Type 1 network in which we propagated the absolute log regulation ratio abs(log(r/g)). We used the filtered lowest boundary of the confidence interval for the microarray measurement based and used the high confidence interaction map. Because type-I networks tend to favour highly connected proteins we tested a normalisation scheme in which we would run the network once with real values (the measured column) and once with simulated values where each measured point is set to 1 instead of the actual signal (the expected column). Afterwards we divided the measured value by the expected value. This normalisation scheme works to a certain extend but will lead to a variance that is directly related to the connectivity of each protein. In the end we dropped the use of Type-I networks due to the many technical problems they pose.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description measured expected final Hugo
Results: HTML CSV LaTeX
Showing element 2358 to 2407 of 3206 in total

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
expected\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
final\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2358\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PROTOCADHERIN 15 PRECURSOR. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0344025\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.156164\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.220297252\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PCDH15\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2359\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GASTRICSIN PRECURSOR (EC 3.4.23.3) (PEPSINOGEN C). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0442218\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.200737\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.220297205\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PGC\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2360\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ZINC FINGER PROTEIN GLI3. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0204267\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.0927234\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.220297142\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GLI3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2361\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SUPPRESSOR OF FUSED. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.152908\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.694099\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.220297105\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SUFU\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2362\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"SOLUTE CARRIER FAMILY 20 (PHOSPHATE TRANSPORTER), MEMBER 1; GLVR-1; PIT-1; GIBBON APE LEUKEMIA VIRUS RECEPTOR 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0465225\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.211181\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.220296807\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SLC20A1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2363\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"SOLUTE CARRIER FAMILY 20 (PHOSPHATE TRANSPORTER), MEMBER 2; GLVR-2; PIT-2; GIBBON APE LEUKEMIA VIRUS RECEPTOR 2; MURINE LEUKEMIA VIRUS, AMPHOTROPIC; RECEPTOR. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0378408\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.171772\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.220296672\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SLC20A2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2364\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LIMB REGION 1 PROTEIN; LIMB REGION 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0589602\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.26764\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.220296667\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
LMBR1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2365\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FARNESYL PYROPHOSPHATE SYNTHETASE (FPP SYNTHETASE) (FPS) (FARNESYL DIPHOSPHATE SYNTHETASE) [INCLUDES: DIMETHYLALLYLTRANSFERASE (EC 2.5.1.1); GERANYLTRANSTRANSFERASE (EC 2.5.1.10)]. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.334917\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.5203\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.220296652\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FDPS\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2366\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PEPSIN A PRECURSOR (EC 3.4.23.1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0604093\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.274218\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.220296625\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2367\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LIPOCALIN-INTERACTING MEMBRANE RECEPTOR. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0719255\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.326494\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.220296545\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
LMBR1L\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2368\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TRANSCRIPTION INITIATION FACTOR TFIID 100 KDA SUBUNIT (TAFII-100) (TAFII100). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.331362\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.50518\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.220147756\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TAF5\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2369\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TRANS-PRENYLTRANSFERASE; POLYPRENYL PYROPHOSPHATE SYNTHETASE. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.294256\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.3369\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.220103224\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PDSS1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2370\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"TRYPTOPHANYL-TRNA SYNTHETASE, MITOCHONDRIAL PRECURSOR (EC 6.1.1.2) (TRYPTOPHAN--TRNA LIGASE) (TRPRS) ((MT)TRPRS). \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0775947\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.352624\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.220049401\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
WARS2\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2371\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TRYPTOPHANYL-TRNA SYNTHETASE (EC 6.1.1.2) (TRYPTOPHAN--TRNA LIGASE) (TRPRS) (IFP53) (HWRS). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
WARS\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2372\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RIBULOSE-5-PHOSPHATE-3-EPIMERASE; RIBULOSE 5-PHOSPHATE 3-EPIMERASE. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.327497\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.48829\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.220049184\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2373\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LENG5 PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0517945\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.235377\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.220049113\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TSEN34\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2374\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0516003\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.234495\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.220048615\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TSEN2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2375\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
THIAMIN PYROPHOSPHOKINASE 1; MOUSE THIAMIN PYROPHOSPHOKINASE HOMOLOG; THIAMINE PYROPHOSPHOKINASE. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0258973\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.117689\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.220048603\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2376\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
THIOREDOXIN-LIKE; PKC-INTERACTING COUSIN OF THIOREDOXIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0698995\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.317655\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.22004848\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GLRX3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2377\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.271141\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.23303\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.219898137\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RIC8A\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2378\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
0.223975\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.01863\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.219878661\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RIC8B\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2379\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BIOTIN--PROTEIN LIGASE (EC 6.3.4.-) (BIOTIN APO-PROTEIN LIGASE) [INCLUDES: BIOTIN--[METHYLMALONYL-COA-CARBOXYLTRANSFERASE] LIGASE (EC 6.3.4.9); BIOTIN--[PROPIONYL-COA-CARBOXYLASE [ATP-HYDROLYZING]] LIGASE (EC 6.3.4.10) (HOLOCARBOXYLASE SYNTHETASE) (HCS); \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.18221\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.828912\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.219818268\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HLCS\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2380\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MOLYBDENUM COFACTOR SYNTHESIS PROTEIN 3 (MOLYBDOPTERIN SYNTHASE SULFURYLASE) (MPT SYNTHASE SULFURYLASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.275917\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.25591\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.219694883\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MOCS3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2381\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.206722\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.940952\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.219694522\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
USP52\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2382\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PROTO-ONCOGENE TYROSINE-PROTEIN KINASE FES/FPS (EC 2.7.1.112) (C-FES). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0453043\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.206215\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.219694494\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FES\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2383\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60S RIBOSOMAL PROTEIN L29 (CELL SURFACE HEPARIN BINDING PROTEIN HIP). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0507615\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.231055\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.219694445\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RPL29\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2384\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ANAPHASE-PROMOTING COMPLEX SUBUNIT 10; ANAPHASE-PROMOTING COMPLEX 10. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.078258\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.356213\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.219694396\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ANAPC10\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2385\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0280218\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.127549\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.219694392\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
C14orf153\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2386\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MOLYBDENUM COFACTOR SYNTHESIS PROTEIN 2 LARGE SUBUNIT (MOLYBDOPTERIN SYNTHASE LARGE SUBUNIT) (MPT SYNTHASE LARGE SUBUNIT) (MOCS2B) (MOCO1- B). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
MOCS2\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2387\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
URM1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2388\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PROTO-ONCOGENE TYROSINE-PROTEIN KINASE FER (EC 2.7.1.112) (P94-FER) (C-FER). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0558685\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.254301\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.219694378\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FER\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2389\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"SUCCINYL-COA LIGASE [GDP-FORMING] ALPHA-CHAIN, MITOCHONDRIAL PRECURSOR (EC 6.2.1.4) (SUCCINYL-COA SYNTHETASE, ALPHA CHAIN) (SCS-ALPHA). \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.245024\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1.11536\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.219681538\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
SUCLG1\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2390\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"SUCCINYL-COA LIGASE [ADP-FORMING] BETA-CHAIN, MITOCHONDRIAL PRECURSOR (EC 6.2.1.5) (SUCCINYL-COA SYNTHETASE, BETAA CHAIN) (SCS-BETAA) (ATP- SPECIFIC SUCCINYL-COA SYNTHETASE BETA SUBUNIT). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
SUCLA2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2391\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"ATP SYNTHASE DELTA CHAIN, MITOCHONDRIAL PRECURSOR (EC 3.6.3.14). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.301597\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.37291\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.219677182\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ATP5D\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2392\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GUANYLATE KINASE (EC 2.7.4.8) (GMP KINASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.353823\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.61155\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.219554466\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GUK1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2393\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SERINE/THREONINE PROTEIN PHOSPHATASE PP1-GAMMA CATALYTIC SUBUNIT (EC 3.1.3.16) (PP-1G). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.518333\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.36093\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.219546111\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PPP1CC\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2394\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"BLOOM'S SYNDROME PROTEIN (EC 3.6.1.-) (RECQ PROTEIN-LIKE 3) (DNA HELICASE, RECQ-LIKE, TYPE 2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.106596\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.485769\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.219437634\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2395\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0914148\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.416755\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.219349018\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MARS2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2396\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SQUALENE MONOOXYGENASE (EC 1.14.99.7) (SQUALENE EPOXIDASE) (SE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.131761\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.60095\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.219254514\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SQLE\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2397\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KYNURENINE 3-MONOOXYGENASE (KYNURENINE 3-HYDROXYLASE). \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.132423\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.60397\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.219254268\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
KMO\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2398\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
UBIQUINONE BIOSYNTHESIS MONOOXGENASE COQ6 (EC 1.14.13.-) (CGI-10). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
COQ6\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2399\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
WILLIAMS BEUREN SYNDROME CRITICAL REGION 20A ISOFORM 2; NOL1/NOP2/SUN GENE FAMILY MEMBER; WILLIAMS-BEUREN SYNDROME CRITICAL REGION PROTEIN 20 COPY A; WILLIAMS BEUREN SYNDROME CHROMOSOME REGION 20. \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.100955\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.460869\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.219053571\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
NSUN5\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2400\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
NSUN2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2401\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
WILLIAMS-BEUREN SYNDROME CRITICAL REGION PROTEIN 20 COPY B. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0801834\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.366045\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.219053395\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2402\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
WILLIAMS BEUREN SYNDROME CHROMOSOME REGION 20C ISOFORM 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0859883\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.392545\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.219053357\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
NSUN5B\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2403\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PROHIBITIN. \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.26817\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1.22481\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.218948245\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
PHB\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2404\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
REPRESSOR OF ESTROGEN RECEPTOR ACTIVITY; B-CELL ASSOCIATED PROTEIN. \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2405\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
INTEGRAL MEMBRANE PROTEIN 2A (E25 PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0252512\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.115441\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.218736844\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ITM2A\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2406\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
INTEGRAL MEMBRANE PROTEIN 2C (TRANSMEMBRANE PROTEIN BRI3) (NPD018). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0256055\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.117061\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.218736385\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ITM2C\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2407\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
INTEGRAL MEMBRANE PROTEIN 2B (TRANSMEMBRANE PROTEIN BRI) [CONTAINS: ABRI/ADAN AMYLOID PEPTIDE]. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0308129\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.140868\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.21873598\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ITM2B\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the bloody hugo identifier as demanded by the BMC Bioinformatics idiots
- http://analysis.yellowcouch.org/